Using crude whole-genome assemblies of Neisseria gonorrhoeae as a platform for strain analysis: Clonal spread of gonorrhea infection in saskatchewan, Canada

Journal of Clinical Microbiology

Volumn 52, Issue 10, 2014, Pages 3772-3776

  Vidovic, Sinisa ^a   Caron, Carolyn ^a   Taheri, Ali ^b   Thakur, Sidharath D ^c   Read, Timothy D ^a,d   Kusalik, Anthony ^a   Dillon, Jo Anne R ^b,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; PENICILLIN DERIVATIVE; SPECTINOMYCIN; TETRACYCLINE;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; CANADA; CLONAL VARIATION; EVOLUTION; GENETIC VARIABILITY; GENOME ANALYSIS; GONORRHEA; NEISSERIA GONORRHOEAE; NONHUMAN; PENICILLIN RESISTANCE; PHENOTYPE; PHYLOGENY; POPULATION STRUCTURE; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; CLASSIFICATION; DNA SEQUENCE; EVALUATION STUDY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PROCEDURES; TRANSMISSION;

GONORRHEA; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NEISSERIA GONORRHOEAE; POLYMORPHISM, SINGLE NUCLEOTIDE; SASKATCHEWAN; SEQUENCE ANALYSIS, DNA;

EID: 84907168910     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01502-14     Document Type: Article

References (32)

1. World Health Organization. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization, Geneva, Switzerland.
2. Public Health Agency of Canada. 2014. National surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae annual summary 2012. Public Health Agency of Canada, Winnipeg, Canada.
3. Tapsall J. 2006. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev. Anti Infect. Ther. 4:619-628. http://dx.doi.org/10.1586/14787210.4.4.619.
4. Martin I, Jayaraman G, Wong T, Liu G, Gilmour M, Canadian Public Health Laboratory Network. 2011. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009. Sex. Transm. Dis. 38:892-898. http://dx.doi.org/10.1097/OLQ.0b013e31822c664f.
5. Bolan GA, Sparling PF, Wasserheit JD. 2012. The emerging threat of untreatable gonococcal infection. N. Engl. J. Med. 366:485-487. http://dx .doi.org/10.1056/NEJMp1112456.
6. Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, Gilmour M. 2012. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010. Sex. Transm. Dis. 39:316-323. http://dx.doi.org/10.1097/OLQ.0b013e3182401b69.
7. Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, Kitawaki J. 2011. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg. Infect. Dis. 17:148-149. http://dx.doi.org/10.3201/eid1701 .100397.
8. Unemo M, Golparian D, Stary A, Eigentler A. 2011. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill. 16: 19998. http://www .eurosurveillance.org/ViewArticle.aspx?Article-Id 19998.
9. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. 2012. High-level cefixime-and ceftriaxone-resistant N. gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56:1273-1280. http://dx.doi.org/10.1128/AAC.05760-11.
10. Lewis DA, Sriruttan C, Muller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M. 2013. Phenotypic and genetic characterization of the first two cases of extended-spectrumcephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J. Antimicrob. Chemother. 68:1267-1270. http://dx.doi.org/10.1093/jac/dkt034.
11. Vidovic S, Thakur SD, Horsman GB, Levett PN, Anvari V, Dillon JR. 2012. Longitudinal analysis of the evolution and dissemination of Neisseria gonorrhoeae strains (Saskatchewan, Canada 2005-2008) reveals three major circulating strains and convergent evolution of ciprofloxacin and azithromycin resistance. J. Clin. Microbiol. 50:3823-3830. http://dx.doi .org/10.1128/JCM.01402-12.
12. Yeung KH, Dillon JR, Pauze M, Wallace E. 1986. A novel 4.9-kilobase plasmid associated with an outbreak of penicillinase-producing Neisseria gonorrhoeae. J. Infect. Dis. 153:1162-1165. http://dx.doi.org/10.1093/infdis/153.6.1162.
13. Ruddock PS, Charland M, Ramirez S, Lopez A, Towers NGH, Arnason JT, Liao M, Dillon JR. 2011. Antimicrobial activity of flavonoids from Piper lanceaefolium and other Colombian medicinal plants against antibiotic susceptible and resistant strains of Neisseria gonorrhoeae. Sex. Transm. Dis. 38:82-88. http://dx.doi.org/10.1097/OLQ.0b013e3181f0bdbd.
14. Gibbs MJ, Armstrong JS, Gibbs AJ. 2000. Sister-scanning: a Monte Carlo procedure for assessing signals in recombinant sequences. Bioinformatics 16:573-582. http://dx.doi.org/10.1093/bioinformatics/16.7.573.
15. Vidovic S, Horsman GB, Liao M, Dillon JR. 2011. Influence of conserved and hypervariable genetic markers on genotyping circulating strains of Neisseria gonorrhoeae. PLoS One 6:e28259. http://dx.doi.org/10.1371/journal.pone.0028259.
16. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599. http://dx.doi.org/10.1093/molbev/msm092.
17. Rzhetsky A, Nei M. 1992. A simple method for estimating and testing minimum evolution trees. Mol. Biol. Evol. 9:945-967.
18. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
19. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed, approved document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Thakur SD, Starnino S, Horsman GB, Levett PN, Dillon JR. 2014. Unique combined penA/mtrR/porB mutations andNG-MASTstrain types associated with ceftriaxone and cefixime MIC increases in a "susceptible" Neisseria gonorrhoeae population. J. Antimicrob. Chemother. 69:1510-1516. http://dx.doi.org/10.1093/jac/dkt543.
21. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics 155:945-959.
22. Jakobsson M, Rosenberg NA. 2007. CLUMPP: a cluster matching and permutation program for dealing with label switching and multimodality in analysis of population structure. Bioinformatics 23:1801-1806. http://dx.doi.org/10.1093/bioinformatics/btm233.
23. Rosenberg NA. 2004. DISTRUCT: a program for the graphical display of population structure. Mol. Ecol. Notes 4:137-138. http://dx.doi.org/10 .1046/j.1471-8286.2003.00566.x.
24. Whiley DM, Limnios EM, Ray S, Sloots TP, Tapsall JW. 2007. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob. Agents Chemother. 51:3111-3116. http://dx.doi.org/10.1128/AAC.00306-07.
25. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshima S, Iwasaki K, Nakayama S, Kitawaki J, Unemo M. 2011. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother. 55:3538-3545. http://dx.doi.org/10.1128/AAC .00325-11.
26. Public Health Agency of Canada. 2011. Report on sexually transmitted infections in Canada: 2009. Centre for Communicable Diseases and Infec-tion Control, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, Canada. http://www.catie.ca/sites/default/files/2009%20Report%20on%20STI%20in%20Canada-EN.pdf.
27. Ilina EN, Oparina NY, Shitikov EA, Borovskaya AD, Govorun VM. 2010. Molecular surveillance of clinical Neisseria gonorrhoeae isolates in Russia. J. Clin. Microbiol. 48:3681-3689. http://dx.doi.org/10.1128/JCM.00565-10.
28. Wylie LJ, Jolly A. 2001. Patterns of chlamydia and gonorrhea infection in sexual networks in Manitoba, Canada. Sex. Transm. Dis. 28:14-24. http://dx.doi.org/10.1097/00007435-200101000-00005.
29. Wylie LJ, Cabral T, Jolly AM. 2005. Identification of networks of sexually transmitted infection: a molecular, geographic, and social network analysis. J. Infect. Dis. 191:899-906. http://dx.doi.org/10.1086/427661.
30. Detels R, Green AM, Klausner JD, Katzenstein D, Gaydos C, Handsfield HH, Pequegnat W, Mayer K, Hartwell TD, Quinn TC. 2011. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex. Transm. Dis. 38:503-509.
31. Bignell C, Garley J. 2010. Azithromycin in the treatment of infection with Neisseria gonorrhoeae. Sex. Transm. Infect. 86:422-426. http://dx.doi.org/10.1136/sti.2010.044586.
32. Bignell C, Fitzgerald M, Guideline Development Group, British Association for Sexual Health and HIV UK. 2011. UK national guideline for the management of gonorrhoea in adults, 2011. Int. J. STD AIDS. 22:541-547. http://dx.doi.org/10.1258/ijsa.2011.011267.